Airway Therapeutics Raises $4.6 Million in Series A Funding
Financing Follows FDA Orphan Designation for Startup Working to Improve Outcomes for Very Premature Infants (Cincinnati OH— September 10, 2014) Airway Therapeutics, a biotechnology company working to prevent a debilitating lung condition in extremely premature infants, has secured $4.6 million in Series A financing. CincyTech led the round, with participation from Cincinnati Children’s Hospital Medical …
New Company Formed to Take Cincinnati Children’s Lung Treatment Research to Premature Babies
Airway Therapeutics LLC has been created to commercialize pulmonary therapy research developed at Cincinnati Children’s Hospital Medical Center and has received a $500,000 investment from CincyTech and Cincinnati Children’s Tomorrow Fund. The investments are part of a projected $1.2 million seed-stage funding round led by CincyTech. CincyTech and the Tomorrow Fund each invested $250,000 in …
- « Previous Page
- 1
- …
- 3
- 4
- 5
